News
-
PSNZ taps potential
Friday | Sep 23 2016THE Pharmaceutical Society of New Zealand (PSNZ) has announced it will appoint a young pharmacist to its National Executive board for a trial period in an attempt to identify and encourage young leaders.
-
Robbers scoot away
Friday | Sep 23 2016BRITISH police are searching for some pharmacy thieves who made their getaway using a stolen mobility scooter (pictured).
-
PSA to deliver vax program
Friday | Sep 23 2016LA TROBE University in Bendigo will be the first university in Victoria to train pharmacy students in the business of immunisation through a new partnership with the Pharmaceutical Society of Australia (PSA).
-
MedAdvisor growth plan
Friday | Sep 23 2016DIGITAL medication adherence company MedAdvisor says its platform continues to surge in popularity, with ceo Robert Read claiming a "nearly 45% share of the pharmacy market" following the recently announced acquisition of rival HealthNotes (PD 02 Sep).
-
Monash pharmacy PhDs
Friday | Sep 23 2016MONASH University Faculty of Pharmacy and Pharmaceutical Sciences has announced it will be offering a new doctoral program from next year, aiming to build upon world-leading research that has given the university its global high profile (PD 16 Sep 16).
-
Dispensary Corner 22 Sep 16
Thursday | Sep 22 2016THE petrol pump is one object you may not have realised is teeming with bacteria.
-
Pharmacists Day
Thursday | Sep 22 2016THE Pharmacy Board of Australia has commended Australia's 29,600 pharmacists for "their important contribution to the health and wellbeing of the Australian community" in the lead-up to World Pharmacists Day.
-
Plasma is Zika-safe
Thursday | Sep 22 2016THE rapidly spreading Zika virus, implicated in microencephaly, has been found to not cause contamination problems in plasma or urine-derived products, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has found.
-
Armodafinil update
Thursday | Sep 22 2016NPS MedicineWise has issued notes on Teva's newly approved Nuvigil (armodafinil), a psychostimulant that aims to improve wakefulness which is indicated for a range of sleep disorders - see www.nps.org.au.